MAPK3 and pancreatic neoplasm: Taken together, these results further validate the fact that the activation of the ERK1/2 signaling pathway affects the functional outcome of TMPRSS4, that is, promotes cell proliferation and inhibits apoptosis in pancreatic cancer.